Filgrastim Recruiting Phase 2 Trials for Severe Aplastic Anemia (SAA) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02918292Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)